Arcutis Biotherapeutics, Inc. (ARQT) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $36.70M | +91.8% |
| 2024 | $19.13M | +283.6% |
| 2023 | $4.99M | +561.4% |
| 2022 | $754.0K | — |
| 2021 | $0 | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $36.70M | +91.8% |
| 2024 | $19.13M | +283.6% |
| 2023 | $4.99M | +561.4% |
| 2022 | $754.0K | — |
| 2021 | $0 | — |